News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
219,416 Results
Type
Article (4962)
Company Profile (20)
Press Release (214434)
Section
Business (82078)
Career Advice (459)
Deals (15036)
Drug Delivery (8)
Drug Development (19035)
Employer Resources (30)
FDA (3668)
Job Trends (3891)
News (119891)
Policy (7496)
Tag
Academia (290)
Africa (181)
Alabama (12)
Alliances (14668)
Alzheimer's disease (201)
Approvals (3655)
Arizona (43)
Asia (11211)
Australia (1522)
Bankruptcy (93)
Best Places to Work (2795)
Biotechnology (21)
C2C Services and Suppliers (25401)
California (576)
Canada (321)
Cancer (105)
Career advice (390)
Cell therapy (26)
China (17)
Clinical research (15445)
Collaboration (26)
Colorado (16)
Compensation (25)
Connecticut (24)
COVID-19 (283)
Data (86)
Delaware (12)
Diagnostics (1950)
Diversity, equity & inclusion (12)
Earnings (39340)
Employer resources (30)
Europe (23679)
Events (36463)
Executive appointments (68)
FDA (3706)
Florida (75)
Funding (35)
GLP-1 (87)
Government (403)
Healthcare (4987)
Hotbed/Location (163143)
Idaho (23)
Illinois (58)
Indiana (30)
Infectious disease (285)
Inflammatory bowel disease (20)
Interviews (53)
IPO (7709)
Job creations (1116)
Job search strategy (360)
Kansas (23)
Layoffs (94)
Legal (2319)
Liver cancer (14)
Lung cancer (19)
Maine (31)
Maryland (82)
Massachusetts (520)
Medical device (3783)
Medtech (3784)
Mergers & acquisitions (7304)
Metabolic disorders (30)
Michigan (46)
Minnesota (86)
Montana (16)
Nebraska (12)
Neuroscience (221)
New Hampshire (13)
New Jersey (203)
New York (209)
NextGen Class of 2024 (1670)
Non-profit (721)
North Carolina (210)
Northern California (286)
Obesity (21)
Ohio (25)
Opinion (27)
Pennsylvania (142)
People (23976)
Phase I (4588)
Phase II (6709)
Phase III (5341)
Pipeline (75)
Postmarket research (625)
Preclinical (1796)
Press Release (66)
Rare diseases (19)
Real estate (1866)
Regulatory (4910)
Reports (13)
Research institute (297)
Resumes & cover letters (68)
South America (273)
Southern California (221)
Startups (1005)
Texas (67)
United States (2620)
Utah (17)
Vaccines (19)
Washington State (55)
Date
Today (36)
Last 7 days (192)
Last 30 days (645)
Last 365 days (11734)
2024 (8264)
2023 (13191)
2022 (18658)
2021 (19679)
2020 (18239)
2019 (13205)
2018 (10205)
2017 (10002)
2016 (9156)
2015 (12118)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
219,416 Results for "trethera corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Trethera Receives $2M NIH Grant for Preclinical Development in the Pediatric Neurologic Disease Acute Disseminated Encephalomyelitis
July 16, 2024
·
6 min read
Business
Globally Recognized Expert in Rare Neurologic Diseases, Dr. Michael Levy, Joins Trethera Scientific Advisory Board
Trethera Corporation announced the appointment of Michael Levy, MD, PhD, to its Scientific Advisory Board.
September 5, 2023
·
5 min read
Biotech Beach
National Institute of Health to Fund Preclinical Development of Trethera Lead Drug, TRE-515, for Treatment of Crohn’s Disease
Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced today that it was awarded a Small Business Technology Transfer (STTR) grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) division of the National Institute of Health (NIH).
September 25, 2023
·
5 min read
Drug Development
Trethera Receives NIH Grant for Preclinical Development in the Pediatric Neurologic Disease Acute Disseminated Encephalomyelitis
Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced today that it was awarded a $600,000 Small Business Technology Transfer (STTR) grant from the National Institute of Allergy and Infectious Diseases (NIAID).
August 14, 2023
·
6 min read
Biotech Beach
Trethera Receives Grant from National Institute of Allergy and Infectious Diseases for the Advancement of TRE-515 in Lupus
Trethera Corporation announced that it was awarded a $0.6M Small Business Technology Transfer grant from the National Institute for Allergy and Infectious Diseases.
June 27, 2023
·
6 min read
Business
Trethera Announces Appointment of Laurent Dubois to Board of Directors
Trethera Corporation, a clinical-stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced the appointment of Laurent Dubois to the Trethera Board of Directors as an independent director.
February 15, 2023
·
4 min read
Biotech Beach
Trethera Receives $2 Million National Cancer Institute Grant for Advancement of Clinically Relevant Biomarkers in Phase 1 Trial
Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced today that it was awarded a $2 million Small Business Innovative Research (“SBIR”) grant from the National Cancer Institute (“NCI”).
May 30, 2023
·
5 min read
Business
Trethera Announces Appointment of R. Boyd Quinnell to Board of Directors
Trethera Corporation (“Trethera”), a clinical-stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced today the appointment of Boyd Quinnell, CPA, MBA, to the Trethera Board of Directors as an independent director.
January 18, 2023
·
4 min read
Biotech Beach
Trethera Announces Poster Presentation at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announces an upcoming poster presentation at the 8th Annual Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis.
January 24, 2023
·
6 min read
Biotech Beach
Trethera Announces Multiple Sclerosis Treatment Poster Presentation at the American Neurological Association Annual Meeting
Trethera Corporation announces an upcoming poster presentation at the 147th Annual Meeting of the American Neurological Association (ANA).
October 4, 2022
·
4 min read
1 of 21,942
Next
